Table 4 Adverse effects during the follow-up
Adverse effect [n (%)] | M3 (n = 162) | M6 (n = 134) |
|---|---|---|
Any | 33 (20.4) | 19 (14.2) |
Constipation | 16 (9.9) | 16 (9.9) |
Injection site reaction | 6 (3.7) | 1 (0.6) |
Dizziness | 3 (1.8) | 1 (0.6) |
Hypertension | 2 (1.2) | 0 |
General discomfort | 2 (1.2) | 1 (0.6) |
Unsteadiness | 1 (0.6) | 0 |
Hypotension | 1 (0.6) | 0 |
Headache worsening | 1 (0.6) | 0 |
Transient facial erythema | 1 (0.6) | 0 |